| Nintedanib for systemic sclerosis–associated interstitial lung disease O Distler, KB Highland, M Gahlemann, A Azuma, A Fischer, MD Mayes, ... New England Journal of Medicine 380 (26), 2518-2528, 2019 | 1454 | 2019 |
| EULAR recommendations for the management of Behçet disease G Hatemi, A Silman, D Bang, B Bodaghi, AM Chamberlain, A Gul, ... Annals of the rheumatic diseases 67 (12), 1656-1662, 2008 | 1018 | 2008 |
| 2018 update of the EULAR recommendations for the management of Behçet’s syndrome G Hatemi, R Christensen, D Bang, B Bodaghi, AF Celik, F Fortune, ... Annals of the rheumatic diseases 77 (6), 808-818, 2018 | 854 | 2018 |
| Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial C Gabay, P Emery, R van Vollenhoven, A Dikranian, R Alten, K Pavelka, ... The Lancet 381 (9877), 1541-1550, 2013 | 845 | 2013 |
| Effect of infliximab on sight-threatening panuveitis in Behcet's disease PP Sfikakis, PG Theodossiadis, CG Katsiari, P Kaklamanis, ... The Lancet 358 (9278), 295-296, 2001 | 651 | 2001 |
| Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down‐regulation of the T cell costimulatory molecule CD40 ligand: an open‐label trial PP Sfikakis, JN Boletis, S Lionaki, V Vigklis, KG Fragiadaki, A Iniotaki, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2005 | 529 | 2005 |
| Anti-TNF therapy in the management of Behçet's disease—review and basis for recommendations PP Sfikakis, N Markomichelakis, E Alpsoy, S Assaad-Khalil, B Bodaghi, ... Rheumatology 46 (5), 736-741, 2007 | 438 | 2007 |
| Waldenstrom’s macroglobulinemia: clinical features, complications, and management MA Dimopoulos, P Panayiotidis, LA Moulopoulos, P Sfikakis, M Dalakas Journal of Clinical Oncology 18 (1), 214-214, 2000 | 404 | 2000 |
| Diagnosis and management of Neuro-Behçet’s disease: international consensus recommendations S Kalra, A Silman, G Akman-Demir, S Bohlega, A Borhani-Haghighi, ... Journal of neurology 261, 1662-1676, 2014 | 387 | 2014 |
| Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients A Arida, K Fragiadaki, E Giavri, PP Sfikakis Seminars in arthritis and rheumatism 41 (1), 61-70, 2011 | 384 | 2011 |
| The present and future of deep learning in radiology L Saba, M Biswas, V Kuppili, EC Godia, HS Suri, DR Edla, T Omerzu, ... European journal of radiology 114, 14-24, 2019 | 382 | 2019 |
| Psoriasis induced by anti–tumor necrosis factor therapy: a paradoxical adverse reaction PP Sfikakis, A Iliopoulos, A Elezoglou, C Kittas, A Stratigos Arthritis & Rheumatism: Official Journal of the American College of …, 2005 | 364 | 2005 |
| The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions PP Sfikakis TNF pathophysiology 11, 180-210, 2010 | 343 | 2010 |
| The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal I Mavrikakis, PP Sfikakis, E Mavrikakis, K Rougas, A Nikolaou, ... Ophthalmology 110 (7), 1321-1326, 2003 | 333 | 2003 |
| Establishing reference values for central blood pressure and its amplification in a general healthy population and according to cardiovascular risk factors A Herbert, JK Cruickshank, S Laurent, P Boutouyrie European heart journal 35 (44), 3122-3133, 2014 | 329 | 2014 |
| Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades–Behçet disease PP Sfikakis, PH Kaklamanis, A Elezoglou, N Katsilambros, ... Annals of Internal Medicine 140 (5), 404-406, 2004 | 318 | 2004 |
| The diagnostic value of ultrasonography-derived edema of the temporal artery wall in giant cell arteritis: a second meta-analysis A Arida, M Kyprianou, M Kanakis, PP Sfikakis BMC Musculoskeletal Disorders 11, 1-8, 2010 | 315 | 2010 |
| Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis CS Crowson, S Rollefstad, E Ikdahl, GD Kitas, PLCM Van Riel, SE Gabriel, ... Annals of the rheumatic diseases 77 (1), 48-54, 2018 | 283 | 2018 |
| Behcet’s disease: a new target for anti-tumour necrosis factor treatment PP Sfikakis Annals of the rheumatic diseases 61 (suppl 2), ii51-ii53, 2002 | 282 | 2002 |
| Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database AM Hoffmann-Vold, Y Allanore, M Alves, C Brunborg, P Airó, LP Ananieva, ... Annals of the rheumatic diseases 80 (2), 219-227, 2021 | 265 | 2021 |
